Diabetic Nephropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 - Research and Markets

Research and Markets has announced the addition of the "Diabetic Nephropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Diabetic Nephropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Diabetic Nephropathy Report is to understand the market and pipeline status of the drugs around the Diabetic Nephropathy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Diabetic Nephropathy Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Diabetic Nephropathy.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Diabetic Nephropathy

7. Phase III Drugs for Diabetic Nephropathy

8. Discontinued Drugs for Diabetic Nephropathy

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/r7sd3k/diabetic

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs , Endocrine and Metabolic Disorders Drugs

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.